LPCN vs MDT · rev $309.5K vs P/E 21, rev $36.36B
Lipocine Inc (LPCN) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Medtronic PLC (MDT) is a medical devices company listed on US.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
LPCN currently screens at market cap $19.3M. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the LPCN and MDT stock pages for the full models.
Not investment advice.